Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen L Chan

Showing results (121-130 of 164) with videos related to

Pageof 17
Sort By:
Clinical Chemistry|May 19, 2022
Single-Molecule Sequencing Enables Long Cell-Free DNA Detection and Direct Methylation Analysis for Cancer PatientsL Y Lois Choy, Wenlei Peng, Peiyong Jiang, et al.
Nature Communications|July 5, 2024
Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thrombosisWei Kang, Caige Huang, Vincent K C Yan, et al.
Hepatobiliary Surgery and Nutrition|June 23, 2023
The Hong Kong consensus statements on unresectable hepatocellular carcinoma: narrative review and update for 2021Tan-To Cheung, Simon Chun-Ho Yu, Stephen L Chan, et al.
The Lancet. Gastroenterology & Hepatology|February 16, 2024
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 studyThomas Yau, Ahmed Kaseb, Ann-Lii Cheng, et al.
JHEP Reports : Innovation in Hepatology|January 4, 2021
Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2Masatoshi Kudo, Peter R Galle, Giovanni Brandi, et al.
Genome Research|August 18, 2020
Detection and characterization of jagged ends of double-stranded DNA in plasmaPeiyong Jiang, Tingting Xie, Spencer C Ding, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 18, 2016
Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in PatientsSarah Berhane, Hidenori Toyoda, Toshifumi Tada, et al.
Cancer Medicine|February 22, 2023
Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantationKyunghye Bang, Andrea Casadei-Gardini, Changhoon Yoo, et al.
Genome Research|February 26, 2024
Genomic origin, fragmentomics, and transcriptional properties of long cell-free DNA molecules in human plasmaHuiwen Che, Peiyong Jiang, L Y Lois Choy, et al.
The New England Journal of Medicine|July 5, 2018
Cabozantinib in Patients with Advanced and Progressing Hepatocellular CarcinomaGhassan K Abou-Alfa, Tim Meyer, Ann-Lii Cheng, et al.
Pageof 17

Showing results (121-130 of 164) with videos related to

Sort By:
Pageof 17
Clinical Chemistry|May 19, 2022
Single-Molecule Sequencing Enables Long Cell-Free DNA Detection and Direct Methylation Analysis for Cancer PatientsL Y Lois Choy, Wenlei Peng, Peiyong Jiang, et al.
Nature Communications|July 5, 2024
Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thrombosisWei Kang, Caige Huang, Vincent K C Yan, et al.
Hepatobiliary Surgery and Nutrition|June 23, 2023
The Hong Kong consensus statements on unresectable hepatocellular carcinoma: narrative review and update for 2021Tan-To Cheung, Simon Chun-Ho Yu, Stephen L Chan, et al.
The Lancet. Gastroenterology & Hepatology|February 16, 2024
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 studyThomas Yau, Ahmed Kaseb, Ann-Lii Cheng, et al.
JHEP Reports : Innovation in Hepatology|January 4, 2021
Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2Masatoshi Kudo, Peter R Galle, Giovanni Brandi, et al.
Genome Research|August 18, 2020
Detection and characterization of jagged ends of double-stranded DNA in plasmaPeiyong Jiang, Tingting Xie, Spencer C Ding, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 18, 2016
Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in PatientsSarah Berhane, Hidenori Toyoda, Toshifumi Tada, et al.
Cancer Medicine|February 22, 2023
Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantationKyunghye Bang, Andrea Casadei-Gardini, Changhoon Yoo, et al.
Genome Research|February 26, 2024
Genomic origin, fragmentomics, and transcriptional properties of long cell-free DNA molecules in human plasmaHuiwen Che, Peiyong Jiang, L Y Lois Choy, et al.
The New England Journal of Medicine|July 5, 2018
Cabozantinib in Patients with Advanced and Progressing Hepatocellular CarcinomaGhassan K Abou-Alfa, Tim Meyer, Ann-Lii Cheng, et al.
Pageof 17